BCA
BMY icon

Bray Capital Advisors’s Bristol-Myers Squibb BMY Stock Holding History

Bray Capital Advisors’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		$281K Buy
4,961
+50
+1% +$2.79K 0.08% 118
2024
Q3 		$254K Buy
4,911
+57
+1% +$2.67K 0.06% 124
2024
Q2 		$202K Sell
4,854
-545
-10% -$24.4K 0.05% 127
2024
Q1 		$293K Buy
5,399
+54
+1% +$2.75K 0.07% 119
2023
Q4 		$274K Buy
5,345
+49
+0.9% +$2.57K 0.08% 120
2023
Q3 		$307K Buy
5,296
+41
+0.8% +$2.51K 0.09% 116
2023
Q2 		$336K Buy
5,255
+36
+0.7% +$2.41K 0.1% 116
2023
Q1 		$362K Buy
5,219
+33
+0.6% +$2.33K 0.11% 117
2022
Q4 		$373K Buy
5,186
+30
+0.6% +$2.26K 0.12% 112
2022
Q3 		$367K Buy
5,156
+30
+0.6% +$2.18K 0.11% 114
2022
Q2 		$395K Buy
5,126
+31
+0.6% +$2.36K 0.12% 112
2022
Q1 		$372K Sell
5,095
-325
-6% -$21.8K 0.1% 116
2021
Q4 		$338K Sell
5,420
-15,799
-74% -$927K 0.08% 122
2021
Q3 		$1.26M Sell
21,219
-1,378
-6% -$90.7K 0.32% 73
2021
Q2 		$1.51M Sell
22,597
-749
-3% -$48.8K 0.39% 67
2021
Q1 		$1.47M Buy
23,346
+31
+0.1% +$1.93K 0.41% 66
2020
Q4 		$1.45M Buy
23,315
+29
+0.1% +$1.78K 0.42% 61
2020
Q3 		$1.4M Buy
23,286
+195
+0.8% +$11.7K 0.49% 56
2020
Q2 		$1.36M Buy
23,091
+4,760
+26% +$285K 0.52% 56
2020
Q1 		$1.02M Buy
18,331
+1,747
+11% +$107K 0.47% 59
2019
Q4 		$1.06M Buy
16,584
+1,912
+13% +$110K 0.38% 68
2019
Q3 		$744K Sell
14,672
-489
-3% -$23K 0.29% 81
2019
Q2 		$688K Buy
15,161
+4,070
+37% +$190K 0.26% 82
2019
Q1 		$529K Buy
11,091
+23
+0.2% +$1.15K 0.22% 86
2018
Q4 		$575K Buy
11,068
+1,158
+12% +$62.2K 0.29% 80
2018
Q3 		$615K Buy
9,910
+20
+0.2% +$1.19K 0.27% 77
2018
Q2 		$547K Buy
9,890
+23
+0.2% +$1.24K 0.25% 75
2018
Q1 		$624K Buy
9,867
+1,281
+15% +$82.4K 0.29% 71
2017
Q4 		$526K Buy
8,586
+1,538
+22% +$96.2K 0.25% 78
2017
Q3 		$449K Buy
+7,048
New +$412K 0.24% 78
2017
Q1 		– Sell
-3,575
Closed -$209K – 118
2016
Q4 		$209K Buy
+3,575
New +$195K 0.13% 107
2016
Q3 		– Sell
-3,894
Closed -$286K – 119
2016
Q2 		$286K Buy
+3,894
New +$275K 0.18% 89
2016
Q1 		– Sell
-3,865
Closed -$266K – 94
2015
Q4 		$266K Buy
3,865
+14
+0.4% +$925 0.17% 104
2015
Q3 		$228K Buy
3,851
+14
+0.4% +$888 0.14% 114
2015
Q2 		$255K Sell
3,837
-927
-19% -$61.1K 0.15% 119
2015
Q1 		$307K Buy
4,764
+20
+0.4% +$1.25K 0.18% 114
2014
Q4 		$280K Buy
+4,744
New +$268K 0.18% 120

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bray Capital Advisors's BMY Position: Q4 2024 in Review

Bray Capital Advisors increased its Bristol-Myers Squibb (BMY) stake by 1% in Q4 2024, buying an estimated $2.79K and bringing the position to 4,961 shares worth $281K. The position accounts for 0.08% of the portfolio, ranked #118.

Bray Capital Advisors first reported a position in BMY in Q4 2014 and has held it in 37 quarters since. The position peaked at $1.51M in Q2 2021. 2,486 funds tracked by Wall St. Rank hold BMY as of Q4 2024.

  • Bray Capital Advisors held 4,961 shares of Bristol-Myers Squibb worth $281K as of Q4 2024.
  • Bray Capital Advisors bought 50 Bristol-Myers Squibb shares in Q4 2024, an estimated $2.79K.
  • Bristol-Myers Squibb made up 0.08% of Bray Capital Advisors's portfolio in Q4 2024, its #118 holding.
  • Bray Capital Advisors first reported a position in Bristol-Myers Squibb in Q4 2014 and has held it in 37 quarters since.
  • Bray Capital Advisors's Bristol-Myers Squibb position peaked at $1.51M in Q2 2021.
  • 2,486 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q4 2024.

Based on Bray Capital Advisors's 13F filing for Q4 2024, filed 3 Feb 2025.